Duchenne Muscular Dystrophy News and Research

RSS
Duchenne muscular dystrophy (DMD) is a progressive muscle disorder that causes the loss of both muscle function and independence. DMD is perhaps the most prevalent of the muscular dystrophies and is the most common lethal genetic disorder diagnosed during childhood today. Each year, approximately 20,000 children worldwide are born with DMD (one of every 3,500 male children).
Researchers identify molecule to fight myotubular myopathy

Researchers identify molecule to fight myotubular myopathy

Urine exRNA may be source of biomarkers for muscular dystrophy

Urine exRNA may be source of biomarkers for muscular dystrophy

Stanford researchers show how to prevent immune response to gene therapy in mouse model

Stanford researchers show how to prevent immune response to gene therapy in mouse model

Muscle dystrophy treatment in dogs with Crispr gene editing

Muscle dystrophy treatment in dogs with Crispr gene editing

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

MDA announces 34 new grants totaling $9.9 million to accelerate neuromuscular research

MDA announces 34 new grants totaling $9.9 million to accelerate neuromuscular research

New project to combat DMD-related fibrosis receives major funding boost

New project to combat DMD-related fibrosis receives major funding boost

Protein known to drive nerve cell survival may protect children from Duchenne cardiomyopathy

Protein known to drive nerve cell survival may protect children from Duchenne cardiomyopathy

Top AI companies join hands to discover novel drugs for DMD

Top AI companies join hands to discover novel drugs for DMD

Glucose-based dietary supplement increases muscle-force in Duchenne muscular dystrophy mouse

Glucose-based dietary supplement increases muscle-force in Duchenne muscular dystrophy mouse

CRISPR technique reduces repetitive behavior in fragile X syndrome mouse models

CRISPR technique reduces repetitive behavior in fragile X syndrome mouse models

KFU medical departments seek to find treatments for hereditary syndromes

KFU medical departments seek to find treatments for hereditary syndromes

New cell-based technologies could help improve understanding of muscle-wasting disease

New cell-based technologies could help improve understanding of muscle-wasting disease

BU postdoctoral researcher wins competitive NIH Pathway to Independence Award

BU postdoctoral researcher wins competitive NIH Pathway to Independence Award

MSU students develop exoskeleton app for patient with Duchenne muscular dystrophy

MSU students develop exoskeleton app for patient with Duchenne muscular dystrophy

Research establishes use of chimeric cells as potential therapy for Duchenne muscular dystrophy

Research establishes use of chimeric cells as potential therapy for Duchenne muscular dystrophy

New guidelines intend to provide template for optimal, most up-to-date DMD care

New guidelines intend to provide template for optimal, most up-to-date DMD care

Plymouth researcher receives grant to further investigate causes of hereditary neuro-tumors

Plymouth researcher receives grant to further investigate causes of hereditary neuro-tumors

Cell therapy for heart disease caused by muscular dystrophy also improves limb strength, study shows

Cell therapy for heart disease caused by muscular dystrophy also improves limb strength, study shows

New CRISPR gene-editing technique can correct majority of mutations that cause DMD

New CRISPR gene-editing technique can correct majority of mutations that cause DMD